Effects of ACE inhibitors on renal function in incipient and overt diabetic nephropathy

Journal of Diabetes and its Complications

Volumn 10, Issue 3, 1996, Pages 133-135

  Parving, Hans Henrik ^a  

^a STENO DIABETES CENTER   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

CONFERENCE PAPER; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DRUG EFFECT; KIDNEY FUNCTION; PRIORITY JOURNAL;

EID: 0030152922     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/1056-8727(96)00031-1     Document Type: Conference Paper

References (23)

1. Parving H-H, Oxenbell B, Svendsen PA, Christiansen JS, Andersen AR: Early detection of patients at risk of developing diabetic nephropathy. Acta Endocrinol 100:550-555, 1982.
2. Viberti GC, Hill RD, Jarrett RJ, Argyropoulos A, Mahmud U, Keen H: Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1:1430-1432, 1982.
3. Mogensen CE, Christiansen CK: Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 311:89-93, 1984.
4. Mathiesen ER, Oxenbøll B, Johansen K, Svendsen PA, Deckert T: Incipient nephropathy in type 1 (insulin-dependent) diabetes. Diabetologia 26:406-410, 1984.
5. Marre M, Chatellier G, Leblanc H, Guyenne T-T, Ménard J, Passa P: Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria. BMJ 297:1092-1095, 1988.
6. Mathiesen ER, Hommel B, Giese J, Parving H-H: Efficacy of captopril in postponing nephropathy in normotensive diabetic patients with microalbuminuria. BMJ 303:81-87, 1991.
7. Viberti GC, Mogensen CE, Groop L, Pauls JF, the European Microalbuminuria Captopril Study Group: Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. JAMA 271:275-279, 1994.
8. Viberti GC, Laffel L, Gans JD: Secondary prevention of diabetic nephropathy by captopril in patients with insulin-dependent diabetes mellitus (IDDM) and microalbuminuria [Abstract]. J Am Soc Nephrol 5:385, 1994.
9. Ravid M, Savin H, Jutrin I, Bental T, Katz B, Lishner M: Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients. Ann Intern Med 118:577-581, 1993.
10. Borch-Johnsen K, Wenzel H, Viberti GC, Mogensen CE: Is screening and intervention for microalbuminuria worthwhile in patients with insulin dependent diabetes. BMJ 306:1722-1723, 1993.
11. Rossing P, Hommel E, Smidt UM, Parving H-H: Impact of arterial blood pressure and albuminuria on the progression of diabetic nephropathy in IDDM patients. Diabetes 42:715-719, 1993.
12. Remuzzi G, Bertani T: Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules? Kidney M 38:384-394, 1990.
13. Rossing P, Hommel B, Smidt UM, Parving H-H: Reduction in albuminuria predicts a beneficial effect on diminishing the progression of human diabetic nephropathy during antihypertensive treatment. Diabetologia 37:511-516, 1994.
14. Weidmann P, Boehlen L, de Courten M, Shaw SG: Human diabetic proteinuria is affected differently by ACE inhibitors, calcium antagonists or conventional therapy [Abstract]. J Am Soc Nephrol 3:339, 1992.
15. Nielsen FS, Rossing P, Gall M-A, Parving H-H: Impaired nocturnal decline in arterial blood pressure in type 2 (non-insulin-dependent) diabetic patients with nephropathy [Abstract]. J Am Soc Nephrol 3:337, 1992.
16. Parving H-H, Rossing P: The use of antihypertensive agents in prevention and treatment of diabetic nephropathy. Curr Opin Nephrol Hypertension 3:292-300, 1994.
17. Mogensen CE: Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy. BMJ 285:685-688, 1982.
18. Parving H-H, Andersen AR, Smidt UM, Svendsen PA: Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy. Lancet 1:1175-1179, 1983.
19. Parving H-H, Andersen AR, Smidt UM, Hommel E, Mathiesen ER, Svendsen PA: Effect of antihypertensive treatment on kidney function in diabetic nephropathy. BMJ 294:1443-1447, 1987.
20. Hommel E, Parving H-H, Mathiesen ER, Edsberg B, Nielsen MD, Giese J: Effect of captopril on kidney function in insulin-dependent diabetic patients with nephropathy. BMJ 293:466-470, 1986.
21. Björk S, Johnsen SA, Nyberg G, Aurell M: Contrasting effects of enalapril and metoprolol on proteinuria in diabetic nephropathy. BMJ 300:904-907, 1990.
22. Lewis E, Hunsicker L, Bain R, Rhode R: The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 329:1456-1462, 1993.
23. Parving H-H, Hommel E: Prognosis in diabetic nephropathy. BMJ 299:230-233, 1989.